New Zealand raises concerns with Elanco/Bayer
New Zealand’s competition watchdog is concerned that Elanco Animal Health’s €7 billion acquisition of Bayer’s animal health business could harm competition for the wholesale supply of several animal healthcare products.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.